MK-0431/ONO-5435 [sitagliptin] phase III clinical study - glimepiride add-on study for patients with type 2 diabetes mellitus.

Trial Profile

MK-0431/ONO-5435 [sitagliptin] phase III clinical study - glimepiride add-on study for patients with type 2 diabetes mellitus.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 May 2016

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Ono Pharmaceutical
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Mar 2009 Actual patient number changed from 138 to 195 as reported by ClinicalTrials.gov.
    • 14 Jun 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top